Anthrax

Infectious Diseases: Third Edition

Volumn 2, Issue , 2010, Pages 1257-1261

  Doganay, Mehmet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84978612028     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04579-7.00128-3     Document Type: Chapter

References (20)

1. Acha P.N., Szyfres B. Zoonozes and communicable diseases common to man and animals, Vol. I. Bacterioses and mycoses 2003, 21-28. Pan American Health Organization, Scientific and Technical Publication No. 580, Washington. 3rd ed.
2. Anthrax in humans and animals 2008, Turnbull P and WHO Anthrax Working Group, World Health Organization, Geneva. 4th ed.
3. Kaya A., Tasyaran M.A., Erol S., Ozkurt Z., Ozkan B. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002, 21:258-261.
4. Irmak H., Buzgan T., Karahocagil M.K., et al. Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases. Acta Med Okayama 2003, 57:235-240.
5. Amidi S., Dutz W., Kohout E., Ronaghy A. Human anthrax in Iran: report of 300 cases and review of literature. Z Tropenmed Parasit 1974, 25:96-104.
6. Doganay M., Almac A., Hanagasi R. Primary throat anthrax: a report of six cases. Scand J Infect Dis 1986, 18:415-419.
7. Sirisanthana T., Brown A.E. Anthrax of the gastrointestinal tract. Emerg Infect Dis 2002, 8:649-651.
8. Kanafani Z.A., Ghossain A., Sharara A.I., Hatem J.M., Kanj S.S. Endemic gastrointestinal anthrax in 1960s Lebanon: clinical manifestations and surgical findings. Emerg Infect Dis 2003, 9:520-525.
9. Frazier A.A., Franks T.J., Galvin J.R. Inhalation anthrax. J Thorac Imaging 2006, 21:252-258.
10. Yakupogullari Y., Koroglu M. Nosocomial spread of Bacillus anthracis. J Hosp Infect 2007, 66:401-402.
11. Jernigan J.A., Stephens D.S., Ashford D.A., et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933-944.
12. Dixon T., Meselson M., Guillemin J., Hanna P.C. Anthrax. N Engl J Med 1999, 341:815-886.
13. Mosser E.M., Rest R.F. The Bacillus anthracis cholesterol-dependent cytolysin, anthrolysin O, kills human neutrophils, monocytes and macrophages. BMC Microbiol 2006, 6:56.
14. Chakrabarty K., Wu W., Booth J.L., et al. Human lung innate immune response to Bacillus anthracis spore infection. Infect Immun 2007, 75(8):3729-3738.
15. Doganay M. Human anthrax in Turkey. Salisbury Med Bull 1996, 87(Special Suppl):8.
16. Meselson M., Guillemin J., Hugh-Jones M., et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994, 266:1202-1208.
17. Tasyaran M.A., Deniz O., Ertek M., Cetin K. Anthrax meningitis: case report and review. Scand J Infect Dis 2002, 34:66-67.
18. Sejvar J.J., Tenover F.C., Stephens D.S. Management of anthrax meningitis. Lancet Infect Dis 2005, 5:287-295.
19. Esel D., Doganay M., Sumerkan B. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Intern J Antimicrob Agent 2003, 22:70-72.
20. Inglesby T.V., O'Toole T., Henderson D.A., et al. Anthrax as a biologic weapon, 2002. Updated recommendations for management. JAMA 2002, 287:2236-2252.